Sage Therapeutics, Inc.(NasdaqGM:SAGE) added to Russell 2000 Value Index
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
13.56 USD | +3.47% | -0.51% | -37.15% |
Apr. 25 | Truist Securities Cuts Sage Therapeutics' Price Target to $18 From $22, Hold Rating Maintained | MT |
Apr. 25 | Transcript : Sage Therapeutics, Inc., Q1 2024 Earnings Call, Apr 25, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.15% | 789M | |
-1.47% | 103B | |
+7.75% | 101B | |
+4.40% | 23.07B | |
-12.13% | 22.23B | |
-4.36% | 18.05B | |
-39.98% | 17.18B | |
-10.63% | 16.94B | |
+6.74% | 14.07B | |
+37.66% | 12.35B |
- Stock Market
- Equities
- SAGE Stock
- News Sage Therapeutics, Inc.
- Sage Therapeutics, Inc.(NasdaqGM: SAGE) added to Russell 2000 Value Index